These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 18327066)
21. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534 [TBL] [Abstract][Full Text] [Related]
22. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280 [TBL] [Abstract][Full Text] [Related]
23. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709 [TBL] [Abstract][Full Text] [Related]
24. [Evidence of the therapeutic effect of antihypertensive therapy: meta-analysis and meta-regression of randomized and controlled trials]. Jovell AJ; Cappelleri JC Med Clin (Barc); 2000; 114 Suppl 2():28-33. PubMed ID: 10916803 [TBL] [Abstract][Full Text] [Related]
25. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171 [TBL] [Abstract][Full Text] [Related]
26. Hypertension in the very elderly: Brief review of management. Zeglin MA; Pacos J; Bisognano JD Cardiol J; 2009; 16(4):379-85. PubMed ID: 19653187 [TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone. Dahabreh IJ; Economopoulos K Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649 [TBL] [Abstract][Full Text] [Related]
28. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers. Papadopoulos DP; Papademetriou V J Hypertens; 2008 May; 26(5):844-52. PubMed ID: 18398322 [TBL] [Abstract][Full Text] [Related]
29. Long-term use of antihypertensive drugs and risk of cancer. Assimes TL; Elstein E; Langleben A; Suissa S Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1039-49. PubMed ID: 18780400 [TBL] [Abstract][Full Text] [Related]
30. Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II. Boutitie F; Oprisiu R; Achard JM; Mazouz H; Wang J; Messerli FH; Gueyffier F; Fournier A J Hypertens; 2007 Aug; 25(8):1543-53. PubMed ID: 17620946 [TBL] [Abstract][Full Text] [Related]
31. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. Corrao G; Zambon A; Parodi A; Poluzzi E; Baldi I; Merlino L; Cesana G; Mancia G J Hypertens; 2008 Apr; 26(4):819-24. PubMed ID: 18327094 [TBL] [Abstract][Full Text] [Related]
32. Calcium channel blockers and coronary heart disease. Inzitari M; Di Bari M; Marchionni N Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169 [TBL] [Abstract][Full Text] [Related]
33. Selecting antihypertensive medication in patients with essential hypertension in Malaysia. Ong HT; Rozina G Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313 [No Abstract] [Full Text] [Related]
34. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Turnbull F; Woodward M; Neal B; Barzi F; Ninomiya T; Chalmers J; Perkovic V; Li N; MacMahon S; Eur Heart J; 2008 Nov; 29(21):2669-80. PubMed ID: 18852183 [TBL] [Abstract][Full Text] [Related]
35. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Cortez-Dias N; Martins S; Belo A; Fiuza M; Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569 [TBL] [Abstract][Full Text] [Related]
36. Headaches and the treatment of blood pressure: results from a meta-analysis of 94 randomized placebo-controlled trials with 24,000 participants. Law M; Morris JK; Jordan R; Wald N Circulation; 2005 Oct; 112(15):2301-6. PubMed ID: 16216977 [TBL] [Abstract][Full Text] [Related]
37. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis. Seminari E; De Silvestri A; Boschi A; Tinelli C AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979 [TBL] [Abstract][Full Text] [Related]
38. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
39. Statins, low-density lipoprotein cholesterol, and risk of cancer. Alsheikh-Ali AA; Trikalinos TA; Kent DM; Karas RH J Am Coll Cardiol; 2008 Sep; 52(14):1141-7. PubMed ID: 18804740 [TBL] [Abstract][Full Text] [Related]
40. Cardiovascular outcomes in the comparative hypertension drug trials: more consensus than controversy. Ong HT Singapore Med J; 2008 Aug; 49(8):599-605; quiz 606. PubMed ID: 18756340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]